Diffuse plane normolipaemic xanthomatosis as a manifestation of monoclonal gammopathy

por Morsink, Linde M., Nijhof, Inger S.
Publicado 2019

Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies

por van der Horst, Hilma J., Nijhof, Inger S., Mutis, Tuna, Chamuleau, Martine E. D.
Publicado 2020

Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update

por Nijhof, Inger S., van de Donk, Niels W. C. J., Zweegman, Sonja, Lokhorst, Henk M.
Publicado 2017

SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies

por Haggenburg, Sabine, Hofsink, Quincy, Rutten, Caroline E., Nijhof, Inger S., Hazenberg, Mette D., Goorhuis, Abraham
Publicado 2022

Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

por Frerichs, Kristine A., Bosman, Patricia W.C., Nijhof, Inger S., Zweegman, Sonja, van de Donk, Niels W.C.J.
Publicado 2019

Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma

por Franssen, Laurens E., Stege, Claudia A. M., Zweegman, Sonja, van de Donk, Niels W. C. J., Nijhof, Inger S.
Publicado 2020

P1411: FIRST EVALUATION OF A MOBILE HEALTH APP DEVELOPED TO MONITOR ACUTE TOXICITIES AFTER CAR T-CELL THERAPY: A THINK ALOUD STUDY WITH PATIENT EXPERTS

por Kos, Milan, Mea Spanjaart, Anne, Van den Berg, Liesbeth, Pennings, Elise R.A., Nijhof, Inger, Peute, Linda, José Kersten, Marie, Van Oijen, Martijn
Publicado 2023

T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma

por Verkleij, Christie P.M., Frerichs, Kristine A., Broekmans, Marloes, Absalah, Saida, Maas-Bosman, Patricia W.C., Kruyswijk, Sandy, Nijhof, Inger S., Mutis, Tuna, Zweegman, Sonja, van de Donk, Niels W.C.J.
Publicado 2020

Lenalidomide for the treatment of relapsed and refractory multiple myeloma

por van de Donk, Niels WCJ, Görgün, Güllü, Groen, Richard WJ, Jakubikova, Jana, Mitsiades, Constantine S, Hideshima, Teru, Laubach, Jacob, Nijhof, Inger S, Raymakers, Reinier A, Lokhorst, Henk M, Richardson, Paul G, Anderson, Kenneth C
Publicado 2012

Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies

por van der Horst, Hilma J., Oostindie, Simone C., Cillessen, Saskia. A. G. M., Gelderloos, Anne T., Overdijk, Marije B., Nijhof, Inger. S., Zweegman, Sonja, Chamuleau, Martine E. D., Breij, Esther C. W., Mutis, Tuna
Publicado 2020

Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: A Randomized, Controlled Trial

por Huygens, Sammy, Hofsink, Quincy, Nijhof, Inger S, Goorhuis, Abraham, Kater, Arnon P, te Boekhorst, Peter A W, Swaneveld, Francis, Novotný, Věra M J, Bogers, Susanne, Welkers, Matthijs R A, Papageorgiou, Grigorios, Rijnders, Bart J, Heijmans, Jarom
Publicado 2022

Cerebrospinal Fluid Penetrance of Daratumumab in Leptomeningeal Multiple Myeloma

por Zajec, Marina, Frerichs, Kristine A., van Duijn, Martijn M., Nijhof, Inger S., Stege, Claudia A.M., Avet-Loiseau, Hervé, Luider, Theo M., de Rijke, Yolanda B., Jacobs, Joannes F.M., van de Donk, Niels W.C.J.
Publicado 2020

Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma

por Frerichs, Kristine A., Minnema, Monique C., Levin, Mark-David, Broijl, Annemiek, Bos, Gerard M. J., Kersten, Marie José, Mutis, Tuna, Verkleij, Christie P. M., Nijhof, Inger S., Maas-Bosman, Patricia W. C., Klein, Saskia K., Zweegman, Sonja, Sonneveld, Pieter, van de Donk, Niels W. C. J.
Publicado 2021

High‐Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action

por Adams, Homer C., Stevenaert, Frederik, Krejcik, Jakub, Van der Borght, Koen, Smets, Tina, Bald, Jaime, Abraham, Yann, Ceulemans, Hugo, Chiu, Christopher, Vanhoof, Greet, Usmani, Saad Z., Plesner, Torben, Lonial, Sagar, Nijhof, Inger, Lokhorst, Henk M., Mutis, Tuna, van de Donk, Niels W.C.J., Sasser, Amy Kate, Casneuf, Tineke
Publicado 2018

P1536: SARS-COV-2 INFECTIONS IN PATIENTS WITH HAEMATOLOGIC MALIGNANCIES: EFFECT OF VACCINATION AND THE DEVELOPMENT OF HYBRID IMMUNITY

por Haggenburg, Sabine, Reuvekamp, Tom, Hofsink, Quincy, Pothast, Cilia R., Dijkland, Romy C., van Dijk, Kayleigh, Broers, Annoek E.C., van Doesum, Jaap, van Binnendijk, Rob S., den Hartog, Gerco, Bhoekhan, Michel S., Haverkate, Nienke J.E., Vogels-Nooijen, Sandra, Nijhof, Inger S., Heemskerk, Mirjam H.M., Rutten, Caroline E., Goorhuis, Abraham, Hazenberg, Mette D.
Publicado 2023

Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities

por Spanjaart, Anne M., Pennings, Elise R.A., Kos, Milan, Mutsaers, Pim G.N.J., Lugtenburg, Pieternella J., van Meerten, Tom, van Doesum, Jaap A., Minnema, Monique C., Jak, Margot, van Dorp, Suzanne, Vermaat, Joost S.P., van der Poel, Marjolein W.M., van Oijen, Martijn G.H., Kuipers, Maria T., Nijhof, Inger S., Kersten, Marie José
Publicado 2023

Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab

por Casneuf, Tineke, Adams, Homer C., van de Donk, Niels W.C.J., Abraham, Yann, Bald, Jaime, Vanhoof, Greet, Van der Borght, Koen, Smets, Tina, Foulk, Brad, Nielsen, Karl C., Rusbuldt, Joshua, Axel, Amy, Lysaght, Andrew, Ceulemans, Hugo, Stevenaert, Frederik, Usmani, Saad Z., Plesner, Torben, Avet-Loiseau, Herve, Nijhof, Inger, Mutis, Tuna, Schecter, Jordan M., Chiu, Christopher, Bahlis, Nizar J.
Publicado 2020

For Better or for Worse: COVID-19 Vaccination during or Early after (Immuno-) Chemotherapy or Hematopoietic Progenitor Cell Transplantation

por Haggenburg, Sabine, Lissenberg-Witte, Birgit I., Van Binnendijk, Robert S., Den Hartog, Gerco, Michel, Bhoekhan S., Haverkate, Nienke J.E., De Rooij, Dennis M., Broers, Annoek E.C., Mutsaers, Pim G.N.J., Van Meerten, Tom, van Doesum, Jaap, Kater, Arnon P., Zweegman, Sonja, Van Gils, Marit J., Goorhuis, Bram, Rutten, Caroline E., Hazenberg, Mette D., Nijhof, Inger S.
Publicado 2021

The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy...

por Spanjaart, Anne M., Pennings, Elise R. A., Mutsaers, Pim G. N. J., van Dorp, Suzanne, Jak, Margot, van Doesum, Jaap A., de Boer, Janneke W., Niezink, Anne G. H., Kos, Milan, Vermaat, Joost S. P., Sijs-Szabo, Aniko, van der Poel, Marjolein W. M., Nijhof, Inger S., Kuipers, Maria T., Chamuleau, Martine E. D., Lugtenburg, Pieternella J., Doorduijn, Jeanette K., Serroukh, Yasmina I. M., Minnema, Monique C., van Meerten, Tom, Kersten, Marie José
Publicado 2023

Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory mu...

por Franssen, Laurens E., Nijhof, Inger S., Bjorklund, Chad C., Chiu, Hsiling, Doorn, Ruud, van Velzen, Jeroen, Emmelot, Maarten, van Kessel, Berris, Levin, Mark-David, Bos, Gerard M.J., Broijl, Annemiek, Klein, Saskia K., Koene, Harry R., Bloem, Andries C., Beeker, Aart, Faber, Laura M., van der Spek, Ellen, Raymakers, Reinier, Sonneveld, Pieter, Zweegman, Sonja, Lokhorst, Henk M., Thakurta, Anjan, Qian, Xiaozhong, Mutis, Tuna, van de Donk, Niels W.C.J.
Publicado 2018